HeartWare estimates raised at Wells Fargo
Wells Fargo increased its estimates for HeartWare after the company announced Q4 results in-line with its guidance. The firm increased its valuation range for the stock to $107-$110 from $90-$94 while maintaining an Outperform rating. :theflyonthewall.com
Add to My Watchlist
What is My Watchlist?